CpG oligodeoxynucleotide nanomedicines for the prophylaxis or treatment of cancers, infectious diseases, and allergies

Nobutaka Hanagata1,2 1Nanotechnology Innovation Station, National Institute for Materials Science, Tsukuba, Ibaraki, 2Graduate School of Life Science, Hokkaido University, Sapporo, Hokkaido, Japan Abstract: Unmethylated cytosine-guanine dinucleotide-containing oligodeoxynucleotides (CpG ODNs), which...

Full description

Saved in:
Bibliographic Details
Main Author: Hanagata N
Format: article
Language:EN
Published: Dove Medical Press 2017
Subjects:
Online Access:https://doaj.org/article/91c8a9dd1b704c99a1bb001f036d8585
Tags: Add Tag
No Tags, Be the first to tag this record!